Skip to content
★ Sign in to follow
SP

Sun Pharma Advanced Research Company Limited Stock: price and insider trades · India

IN·Mcap ₹60.1BHealth Care

Sun Pharma Advanced Research Company Limited: what insiders have been doing

We have very little insider data for Sun Pharma Advanced Research Company Limited so far: the most recent filing dates from 21 May 2026. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 5,643 of 26,911 companies
66.4
score / 100
Value
72
Quality
61
FCF yld-4.4%
Earn yld26%
EV/EBITDA4.1x
ROE277%
Gross mgn-31%
Net mgn·
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹185.07
Analyst consensus
·
Income statement
Revenue₹391.5M
Gross profit-₹122.4M-31% margin
EBITDA₹15.9B4074% margin
Net income₹15.5B83.0% margin
Valuation
PER (trailing)3.8x
P/Book4.5x
Beta0.65
Balance sheet & cash
Market cap₹60.1B
Total debt₹5.6B
Free Cash Flow-₹2.6B
Debt / Equity42%
Profitability & ownership
ROE276.9%
ROA79.7%
% insiders73.0%
% institutions1.8%
Last declaration on 21 May 2026
Declarations14 total
  • ●
    Related company / holdingExecutives
    1B INR0SEBI
    38,510,000 shares@ ₹39.00100.0% of flowWarrantsPreferential OfferSEBI:06deb6f2bd82ecc844e6caa2f2429aafd894fc5a
  • ●
    Executives
    420M INR4SEBI
    2,200,000 shares@ ₹190.8017.0% of flowEquity SharesSEBI:d0a46e3d44eacc4950c28186ef7f97f29115ddf0
  • ●
    Executives
    343M INR10SEBI
    1,800,000 shares@ ₹190.80100.0% of flowEquity SharesSEBI:5e27a0674736882893a4fd94477da54af480cadd
  • ●
    Executives
    3B INR8SEBI
    25,280,899 shares@ ₹133.5056.2% of flowEquity SharesSEBI:281cdbaee9aa31e4f1f495d58e3b6d3b61469584
  • ●
    Executives
    0SEBI
    25,280,899 sharesWarrantsSEBI:717d1c21621b5659fd48f449281d056c402d2c29
  • ●
    Executives
    406M INR4SEBI
    1,900,000 shares@ ₹213.8016.6% of flowEquity SharesSEBI:ea4d71a751f9e82ae9d4a61c71254dcdcc25afd5
  • ●
    Executives
    772M INR5SEBI
    3,080,000 shares@ ₹250.7032.8% of flowEquity SharesSEBI:efb9234db6543e130be7796a19c7bb39d865085d
  • ●
    Executives
    229M INR3SEBI
    1,000,000 shares@ ₹229.4010.3% of flowEquity SharesSEBI:52e4ddad807c12e061d3bc11a692cba7ac61cc51
  • ●
    Executives
    75M INR2SEBI
    430,000 shares@ ₹174.203.3% of flowEquity SharesSEBI:5830e15b044e464e4dd85ed682aebd846c77d4d2
  • ●
    Executives
    178M INR3SEBI
    870,000 shares@ ₹204.407.8% of flowEquity SharesSEBI:ad326dd6338043ef62c87907f7b9c213bdfed2a1
  • ●
    Executives
    282M INR3SEBI
    1,300,000 shares@ ₹216.8512.2% of flowEquity SharesSEBI:2778cb818d5014d23cd34664d203159772da8bf7
  • ●
    Executives
    1B INR4SEBI
    8,426,966 shares@ ₹133.5019.3% of flowEquity SharesSEBI:785977ad4583f1d47711324b3907b344d060f820
  • ●
    Executives
    0SEBI
    8,426,966 sharesWarrantsSEBI:9d89002c7269e982fe9495442694bb03b8205ec7
  • ●
    Executives
    1B INR0SEBI
    33,707,865 shares@ ₹44.5024.5% of flowWarrantsSEBI:7bd64a2dda8a9ab710dda4b7cbcfec9000131d34

14 of 14 declarations

About Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited is a pharmaceutical research company focused on developing new drugs. It is part of the Sun Pharma group, one of the largest drug manufacturers in India.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations